Regulatory

Documents

AGENCY LISTINGS

Oct. 18, 2019

Your one stop reference for all healthcare associations, groups and bodies of governance.

Regulatory

Biden Administration Announces Updated Resource to Support the Inclusion of Children with Disabilities in Early Childhood Programs

Nov. 30, 2023

Patient Satisfaction

FDA Approves First Therapy for Rare Type of Non-Cancerous Tumors

Nov. 28, 2023

Sourcing & Logistics

Biden Administration Announces New Actions to Strengthen Medical Supply Chain

Nov. 28, 2023

Regulatory

FDA issues final guidance: Assessing the Credibility of Computational Modeling and Simulation in Medical Device Submissions

Nov. 21, 2023

Regulatory

New social determinants of health resources released

Nov. 20, 2023

Regulatory

Regulatory

HHS establishes Secretary’s Advisory Committee on Long COVID

Nov. 20, 2023

Regulatory

FDA issues warning letter to Amazon

Nov. 16, 2023

Regulatory

National Climate Assessment 5 unveiled

Nov. 14, 2023

Regulatory

Harris Administration agencies sign agreement to address wildfire risk

Nov. 10, 2023

Regulatory

‘Birthing-Friendly’ designation on web-based care compare tool launches

Nov. 8, 2023

Regulatory

Biden Administration takes actions to improve rural healthcare

Nov. 3, 2023

Regulatory

First Federal campaign for hospitals to decrease healthcare workers burnout launches

Nov. 1, 2023

Regulatory

FDA announces approval for interchangeable biosimilar for inflammatory diseases

Nov. 1, 2023

The U.S. Food and Drug Administration approved Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara (ustekinumab) for several inflammatory diseases

Regulatory

HHS proposes rule to create disincentives for healthcare providers committing information blocking

Oct. 31, 2023

The U.S. Department of Health and Human Services released a proposed rule for public comment that would establish disincentives for healthcare providers found by the HHS Office...

Regulatory

FDA advises on possible risks probiotics may cause to preterm infants in hospitals

Oct. 27, 2023

The agency is concerned as these products can be dangerous for preterm infants and are being illegally sold to treat or prevent diseases in preterm infants in hospital settings...

Regulatory

FDA expands pediatric indication for entrectinib and approves new pellet formulation

Oct. 26, 2023

The Food and Drug Administration granted accelerated approval to entrectinib (Rozlytrek, Genentech Inc.) for pediatric patients on Oct. 20

Regulatory

Health workers report harassment, symptoms of poor mental health, and difficult working conditions

Oct. 25, 2023

A new report from the CDC says that more than double the number of health workers reported harassment at work in 2022 than in 2018